Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None

Similar documents
The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD

The Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

The Athlete s Heart. Critical Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

Echo Evaluation of the Heart of an Athlete

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest

Exercise Cardiomyopathy

Sudden Death in Athletes: What is the role of ECG Screening?

Athlete s Heart vs. Cardiomyopathy

Athlete s Heart vs. Cardiomyopathy

Cardiac hypertrophy : differentiating disease from athlete

Novel echocardiographic modalities: 3D echo, speckle tracking and strain rate imaging. Potential roles in sports cardiology. Stefano Caselli, MD, PhD

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

Prevalence of Modified ARVC Task Force Criteria in Elite Male Athletes

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD

Echographic tricky aspects in the athlete's heart

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen

Cardiomyopathy. ACOI IM Board Review 2018 Martin C. Burke DO, FACOI

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

27-year-old professionnal rugby player: asymptomatic

Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Strain Imaging: Myocardial Mechanics Simplified and Applied

Jonathan Kim MD, FACC

Endurance Exercise and Cardiovascular Health

How to Read an Athlete s ECG. Sanjay Sharma BSc (Hons), MD, FRCP, FESC

Highlights from EuroEcho 2009 Echo in cardiomyopathies

Utility of Echocardiography

Restrictive Cardiomyopathy

Historical Notes: Clinical Exercise Testing in the Athlete. An Efficient Heart. Structural Changes, Cont. Coronary Arteries

Hypertension in Aortic Valve Disease

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS

Athletes with cardiac disease; dead and buried or chance for resurrection?

CLINICAL RESEARCH ON CARDIOVASCULAR ALTERATION ON 86 S PROFESSIONAL ATHLETES IN IRAN

Stress Testing in Valvular Disease

Hypertrophic Cardiomyopathy: beyond gradient and wall thickness

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations

Natural History and Echo Evaluation of Aortic Stenosis

Primary Mitral Regurgitation

How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

Screening of Children and Adolescents at Risk of Sudden Cardiac Arrest: What Is the Utility of Non-Invasive Imaging?

Dr. Dermot Phelan MB BCh BAO PhD European Society of Cardiology 2012

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre

Pulmonary Regurgitation after TOF Repair. How to Assess and Options of Management? Worakan Promphan, MD.FSCAI.

Unusual Causes of Aortic Regurgitation. Case 1

What s New in Cardiac MRI

Cardiac Care in pa+ents with Duchenne muscular dystrophy

4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification

Cardiac MRI: Clinical Application to Disease

EKG screening in athletics

Severe Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

imagine 2018 Echocardiography Today - Do, Learn, Do More, Learn More November 3-4, 2018 Georgia Technology Hotel and Conference Center

Advanced imaging of the left atrium - strain, CT, 3D, MRI -

Pathophysiology: Heart Failure

Diastolic Heart Function: Applying the New Guidelines Case Studies

Cardiac MRI: Clinical Application to Disease

Tissue Doppler and Strain Imaging

Tissue Doppler and Strain Imaging

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Dr Navin Chandra Clinical Research Fellow in Cardiology St George s University of London

Outline. Many Health Benefits of exercise for all ages. Over age 35 years- drawn to endurance exercise. Risks of exercise

Interpretation and Consequences of Repolarisation Changes in Athletes

Exercise Testing/Echocardiography in Asymptomatic AS

Professor Sanjay Sharma St George s University of London

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

Evaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death

Low Gradient Severe? AS

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on)

Pregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia

HAND held echocardiography a dangerous toy?

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

The new Guidelines: Focus on Chronic Heart Failure

Etiology, Classification & Management. Sheba Medical Center Cardiology Department Matthew Wright St. George s University of London

ASE Guidelines on Aortic Regurgitation What Do I Measure? Case Studies

DISCLOSURE. Echocardiography in Systemic Diseases: Questions. Relevant Financial Relationship(s) None. Off Label Usage None 5/7/2018

Cardiovascular Imaging Endpoints in Oncology Clinical Trials

Asymptomatic Valvular Disease:

9/23/2011. Cardiac MRI Evaluation of Cardiomyopathy and Myocarditis. Primary Hypertrophic Cardiomyopathy. Cardiomyopathy.

Imaging in dilated cardiomyopathy : factors associated with a poor outcome

CARDIAC BENEFICIAL EFFECTS AND ADAPTATIONS IN ATHLETES

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

I have nothing to disclose. Research support from: Cardiac Risk in The Young

How does taking warfarin affect Exercise Regimen? By Dr.*~LoOKTaO ~* ÿ

Michigan Society of Echocardiography 30 th Year Jubilee

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION

Hypertrophic Cardiomyopathy or «Athlete s Heart»

2/4/2011. Nathan Kerner, M.D.

Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR. Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM

Cardiovascular Impacts of long-term endurance exercise: Implications of athlete s heart

Atrial dysfunction and chronotropic incompetence

Aortic valve Stenosis: Insights in the evaluation of LV function. Erwan DONAL Cardiologie CHU Rennes

Transcription:

Athlete's Heart vs. Cardiac Pathology Clinical Approaches Echo Florida 2012 Aaron L. Baggish MD Cardiovascular Performance Program Cardiac Ultrasound Laboratory Division of Cardiology Massachusetts General Hospital Boston, MA Assistant Professor of Medicine, HMS Conflicts of Interest: None Disclosures / Funding: American Heart Association American Society of Echocardiography CIMIT NIH / NIDA Athlete s Heart: Clinical Relevance 1950 s BMI = 23.8 2000 s BMI = 27.6 2000 s 1

The Athlete in CV Medicine Where do they come from and Why? The Athlete Sudden Death Asymptomatic Symptomatic Athlete s Heart Vs. Pathology Syncope Arrhythmias ASHD HTN Stamina Athlete s Heart: Care of the Athlete The Athlete Asymptomatic or Symptomatic Athlete s Heart Vs. Pathology Pre-participation screening Insurance physicals Well checks Pre-operative assessment Risk factors assessment visits Cardiac Remodeling: Health vs. Disease Hemodynamic Stress of Sport Pathophysiology of Disease 2

Cardiac Remodeling: Physiology Classic concept of LV remodeling Aortic Regurgitation Aortic Stenosis Volume Challenge Pressure Challenge Cardiac Remodeling: Physiology Endurance Activities Strength Activities Sustained CO 4 to 5 times rest HR & SV Vasodilation Volume Challenge Repetitive SBP Systolic BP > 200 mmhg Skeletal Mus. Contraction Vasoconstriction Pressure Challenge Cardiac Remodeling: Physiology Annals of Int Med 1975;82:521 3

Cardiac Remodeling: Physiology Weiner. Prog Cardio Vasc Dis. 2012 Cardiac Remodeling: Physiology Can we separate athletic remodeling from pathology using using echo? YES (>95% of the time) IF.. We know what is normal and remain focused on what the clinical question is? The Gray Zone: Health vs. Disease The 3 Cardinal Forms of Clinical Uncertainty Left Chamber Dilation Right Chamber Dilation Myocardial Thickening Eccentric LVH RV Dilation Concentric LVH Familial DCM Idiopathic DCM Toxic DCM Valvular Heart Disease ARVC Exercise RVC (?) HCM Hypertensive CMP Non-compaction Infiltrative CMP 4

Evaluation Tool Kit Understanding of Exercise-Induced Cardiac Remodeling Medical History & Physical Examination 12-Lead ECG 2D-Echocardiography Cardiac MRI Advanced TTE Imaging Exercise Testing (+/- Imaging) Ambulatory Rhythm Monitoring Genetic Testing Prescribed Detraining Uncertainty #1: LV Chamber Enlargement : Expected with Endurance or Mixed Hemodynamic Training Accompanied by Proportionate Increase in LV Wall Thickening (Symmetric Eccentric LVH) Accompanied by normal to low normal resting LVEF (~ 50%) Left Chamber Dilation TDI / Strain assessment with preserved or enhanced function Accompanied other chamber enlargement (RV, LA) Uncertainty #1: LV Chamber Enlargement ~40% of male athletes Pelliccia et al. Annals of Int Med 1999 5

Uncertainty #1: LV Chamber Enlargement 25% of US college athletes exceed gender recommended LVIDd limit Weiner et al. JASE 2012 Uncertainty #1: LV Chamber Enlargement Am J Physiol. 2008 BMJ 2012 Uncertainty #1: LV Chamber Enlargement vs. Pathologic Eccentric LVH NOT isolated chamber dilation Accompanied RV and LA chamber enlargement LVIDd cut-offs are not helpful Lowish resting LVEF with normal or enhanced LV mechanics is physiology Left Chamber Dilation If in doubt, exercise testing is VERY useful: to confirm LV augmentation and to document supranormal exercise capacity This is not an HCM mimicker 6

Uncertainty #2: RV Chamber Enlargement : Expected with Endurance or Mixed Hemodynamic Training Global RV process without sacculation, aneurysmal dilation, segmental dysfunction, or fibrosis (?) Accompanied by concomitant LV enlargement but no RVH Right Chamber Dilation Accompanied by normal to low normal resting FAC / RVEF (~ 45%) TDI / Strain assessment with preserved or enhanced function Uncertainty #2: RV Chamber Enlargement D Andrea et al. IJC 2011 Uncertainty #2: RV Chamber Enlargement Oxborough et al. JASE 2012 7

Uncertainty #2: RV Chamber Enlargement Uncertainty #2: RV Chamber Enlargement Whyte et al. JAP 2011 Exercise- Induced CMP??? LaGerche et al. EHJ 2011 Uncertainty #2: RV Chamber Enlargement vs. Pathologic RV dimensions cut-offs are not helpful Always associated with LV remodeling Global dilation with low normal function is physiologic if not associated with: -Structural ARVC features (sacc., trabec., M.B.) -Functional ARVC features (segmental dysf.) -ECG and saecg criteria for ARVC Right Chamber Dilation If in doubt, comprehensive exercise test and rhythm monitoring Isolated finding of fibrosis more work needed? 8

Uncertainty #3: Thick LV Walls : Least frequent but most problematic issue Expected with strength (isometric) training Mild symmetric concentric LVH Accompanied by no changes south of the mitral valve Myocardial Thickening Accompanied by normal to hyperdynamic resting LVEF (>60%) Marked regional thickening not physiologic until proven otherwise! Uncertainty #3: Thick LV Walls Adult Athletes Junior Athletes Pellicia et al NEJM 1991 Sharma et al JACC 2002 Uncertainty #3: Thick LV Walls Not a single healthy college athlete with walls > 14 Weiner et al. JASE 2012 9

Uncertainty #3: LV Thick Walls Prescribed Detraining 5 published studies All eccentric LVH Plasticity proven Concentric LVH?? Weiner JACC 2012 Uncertainty #3: Thick LV Walls vs. Pathologic concentric LVH is symmetric w/o regional variation.marked assymmetry is pathology until proven otherwise Wall thickness cut-offs are VERY helpful Accurate absolute thicknesses > 15 are pathologic until proven otherwise Myocardial Thickening Exercise testing (CPET) is a very useful discriminator Detraining may be necessary to arrive at a final Dx The Gray Zone: Health vs. Disease The 3 Cardinal Forms of Clinical Uncertainty Left Chamber Dilation Right Chamber Dilation Myocardial Thickening Eccentric LVH RV Dilation Concentric LVH Familial DCM Idiopathic DCM Toxic DCM Valvular Heart Disease ARVC Exercise RVC (?) HCM Hypertensive CMP Non-compaction Infiltrative CMP 10

Thank You! 11